A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/24 (2006.01) A61K 31/138 (2006.01) A61P 15/08 (2006.01)
Patent
CA 2457849
The invention provides a protocol leading to improved embryo implantation rates and/or decreased miscarriage rates in which hCG, or a bio-analogue, is administered during the follicular phase.
L'invention concerne un protocole menant à des taux d'implantation embryonnaire améliorés et/ou à des taux réduits de fausse-couche, dans lequel hCG, ou un bio-analogue, est administré lors de la phase folliculaire.
Applied Research Systems Ars Holding N.v.
Borden Ladner Gervais Llp
Merck Serono Sa
LandOfFree
Use of hcg in controlled ovarian hyperstimulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of hcg in controlled ovarian hyperstimulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of hcg in controlled ovarian hyperstimulation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1915716